INTENSITY THERAPEUTICS, INC.

INTS · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.0B · 7 employees
88
SEC Filings
$4.39
Close 2026-05-29
7
Employees

Business Summary

OVERVIEW Intensity Therapeutics, Inc. is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction leading to anti-cancer immune activation. Our new approach involves the direct injection into tumors of a unique product created from our DfuseRx SM discovery platform. Intratumoral (IT) treatment, or treatment designed to contain a drug inside a tumor without spreading to the rest of the body, has been an objecti...

Latest Stock Quote

INTS 2026-05-29 $4.39 O:$4.4 H:$4.5899 L:$4.38 Vol:0.0M VWAP:$4.4302
origin leaf: b54821c7fd38fbdc1227f1c7e013ade8369538ea0e6ab3536e95eb8d88181f1e

Next Earnings

Q2 FY2026 — expected 2026-09-09

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-272025-12-310001567264-26-000024EDGAR88K words
2025-03-132024-12-310001567264-25-000010EDGAR—
2024-03-142023-12-310001628280-24-011207EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001567264-25-000103EDGAR16K words
2025-08-072025-06-300001567264-25-000077EDGAR—
2025-05-132025-03-310001567264-25-000039EDGAR—
2024-11-132024-09-300001567264-24-000052EDGAR—
2024-08-082024-06-300001567264-24-000041EDGAR—
2024-05-092024-03-310001567264-24-000010EDGAR—
2023-11-132023-09-300001213900-23-085791EDGAR—
2023-08-142023-06-300001213900-23-066740EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-270001567264-26-000025EDGAR3K words
2026-03-230001567264-26-000021EDGAR—
2026-03-060001567264-26-000014EDGAR—
2026-03-050001567264-26-000011EDGAR—
2026-02-130001567264-26-000007EDGAR—
2025-12-050001567264-25-000111EDGAR—
2025-12-040001567264-25-000109EDGAR—
2025-11-060001567264-25-000104EDGAR—
2025-10-310001628280-25-047855EDGAR—
2025-10-230001567264-25-000096EDGAR—

88 total filings indexed. 67 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001567264
TickerINTS
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.intensitytherapeutics.com
Listed2023-06-30

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 66790834efce7daa230b4daa106851061d7a20c923802d6d823c9c28de9de17c
parent: 4cafea7c0b2d17d1d78ff2fad7affc6c6eddd154e9bd22858c9b3ece8dd4e2cf
content hash: 897009467b4bc91cf87da31c73daec9edd0af37be0ac0f97718fc5f6cb4faad2
signed: 2026-06-02T19:01:32.271Z
sources: 12 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf